Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |